882
L. Fuentes et al.
LETTER
(7.83 mmol, 1.0 M solution). The reaction mixture was
refluxed for 5 h. Then, the mixture was cooled to r.t., H2O
was added (5 mL), the phases were separated and the
aqueous phase was extracted with EtOAc (2 × 15 mL). The
combined organic phases were dried over Na2SO4 and the
solvent was removed under reduced pressure. The residue
was purified by column chromatography on silica gel, and
then recrystallized in CH2Cl2–hexane to give the
for 8 h, then phases were separated and the aqueous phase
was extracted with EtOAc (3 × 25 mL). The combined
organic phases were dried over Na2SO4 and the solvent was
removed under reduced pressure. The residue was purified
by column chromatography on silica gel to give an
inseparable mixture of diastereomeric epoxyamides 13a and
13b in a 50:50 ratio as a pale yellow oil (2.97 g, 70%); [α]D
20
–23.9 (c = 1.0, CH2Cl2). NMR data is reported as a mixture
of diastereoisomers and E/Z rotamers. 1H NMR (400 MHz,
CDCl3): δ = 1.60 (d, J = 6.8 Hz), 1.64 (s), 1.66 (d, J = 6.4
Hz), 2.30–2.41 (m), 2.56–2.64 (m), 2.70–2.78 (m), 2.87–
2.99 (m), 3.23–3.35 (m), 3.38–3.61 (m), 3.66 (dd, J = 3.6,
1.6 Hz), 3.79 (dd, J = 6.0, 2.0 Hz), 4.19 (ddd, J = 20.8, 11.6,
1.6 Hz), 5.33 (q, J = 6.8 Hz), 5.39 (q, J = 6.8 Hz), 6.13 (app
quint., J = 7.2 Hz), 6.75 (d, J = 7.8 Hz), 6.88–7.03 (m), 7.18–
7.45 (m), 8.04 (br). 13C NMR (100 MHz, CDCl3): δ = 16.5,
18.3, 18.5, 23.9, 24.2, 26.7, 26.8, 28.1, 28.1, 43.4, 43.5, 44.0,
44.0, 51.8, 51.9, 54.7, 54.9, 57.4, 57.5, 57.9, 58.0, 58.1, 58.3,
83.3, 83.6, 115.0, 115.2, 115.3, 116.4, 117.9, 118.2, 119.3,
119.3, 122.4, 122.4, 123.0, 123.0, 123.1, 124.3, 124.4,
125.5, 125.6, 126.7, 127.1, 127.8, 127.9, 127.9, 128.0,
128.1, 128.6, 128.7, 128.8, 129.6, 130.3, 135.2, 135.3,
135.4, 139.2, 139.8, 140.0, 149.4, 149.7, 166.5, 166.6,
166.7. HRMS (FAB): m/z [M + H]+ calcd for C32H35N2O4:
511.2597; found: 511.2550.
corresponding product. (5S,6R)-5-Hydroxy-6-phenyl-3-
[(S)-1-phenylethyl]-2,3,5,6-tetrahydro-1H-azocino[5,4-
b]indol-4(7H)-one (15a): obtained as a white solid (0.25 g,
79%); mp 231–267 °C (decomp.); [α]D20 –7.1 (c = 1.0,
CH2Cl2). The NMR data is reported as a mixture of rotamers.
1H NMR (400 MHz, CDCl3): δ = 1.47 (d, J = 7.2 Hz), 1. 57
(d, J = 7.2 Hz), 1.99 (br), 2.95 (ddd, J = 16.0, 9.6, 4.0 Hz),
3.11 (dt, J = 16.0, 8.4 Hz), 3.39 (ddd, J = 14.4, 9.6, 8.0 Hz),
3.69 (ddd, J = 14.8, 8.8, 4.0 Hz), 4.28 (d, J = 9.6 Hz), 4.98
(d, J = 9.6 Hz), 5.88 (q, J = 7.2 Hz), 5.94 (q, J = 7.2 Hz), 6.34
(s), 6.53–6.59 (m), 6.82–6.91 (m), 7.04–7.08 (m), 7.15–7.34
(m), 8.40 (br), 8.55 (br). 13C NMR (100 MHz, CDCl3): δ
=16.0, 23.1, 40.3, 42.6, 51.2, 52.4, 53.0, 72.3, 106.5, 110.2,
110.3, 110.7, 117.7, 118.6, 119.0, 121.5, 122.6, 122.9,
127.0, 127.0, 127.2, 127.5, 127.7, 127.8, 128.2, 128.4,
128.4, 128.5, 128.8, 133.8, 134.0, 135.4, 135.5, 135.7,
138.0, 138.2, 139.4, 139.8, 140.2, 169.9, 174.9. HRMS
(FAB): m/z [M + H]+ calcd for C27H27N2O2: 411.2073;
found: 411.2060.
(5R,6S)-5-Hydroxy-6-phenyl-3-[(S)-1-phenylethyl]-
2,3,5,6-tetrahydro-1H-azocino[5,4-b]indol-4(7H)-one
(15b): obtained as a white solid (0.38 g, 80%); mp 147–150
°C; [α]D20 –1.2 (c = 1.0, CH2Cl2). The NMR data is reported
as a mixture of rotamers. 1H NMR (400 MHz, CDCl3): δ =
0.78 (d, J = 6.8 Hz), 1.59 (d, J = 7.2 Hz), 3.03–3.20 (m),
3.20–3.30 (m), 3.39–3.53 (m), 3.87 (d, J = 8.8 Hz), 4.27 (d,
J = 8.8 Hz), 4.95 (t, J = 8.8 Hz, 1 H), 5.83 (q, J = 6.8 Hz, 1
H), 5.99 (q, J = 6.8 Hz), 7.13–7.36 (m), 7.51–7.54 (m), 8.02
(s), 8.20 (s). 13C NMR (100 MHz, CDCl3): δ = 15.6, 23.4,
41.0, 41.3, 51.6, 51.9, 53.5, 72.3, 106.8, 110.7, 110.8, 117.3,
118.7, 119.2, 119.4, 119.5, 121.9, 123.0, 127.3, 127.4,
127.5, 127.5, 127.8, 128.3, 128.5, 128.6, 128.9, 132.9,
134.3, 135.3, 135.7, 137.9, 139.4, 139.9, 140.0, 169.6,
174.7. HRMS (FAB): m/z [M + H]+ calcd for C27H27N2O2:
411.2073; found: 411.2079.
(12) General Procedure for the Intramolecular Ring
Opening: To a solution of 13a/13b (2.00 g, 3.91 mmol) in
anhyd MeCN (45 mL) at r.t. was added Cu(OTf)2 (0.28 g,
0.78 mmol) dissolved in anhyd MeCN (5 mL). The reaction
mixture was stirred for 30 min before H2O (15 mL) was
added. The phases were separated and the aqueous phase
was extracted with EtOAc (3 × 25 mL). The organic phase
was dried over Na2SO4, and the solvent was evaporated
under reduced pressure. The residue was purified by column
chromatography on silica gel or recrystallized with EtOAc–
hexane to give 14a (0.80 g, 40%) and 14b (0.84 g, 42%).
(5S,6R)-tert-Butyl-5-hydroxy-4-oxo-6-phenyl-3-[(S)-1-
phenylethyl]-3,4,5,6-tetrahydro-1H-azocino[5,4-
b]indole-7(2H)-carboxylate (14a): Obtained as a white
solid (0.80 g, 40%); mp 185–186 °C; [α]D20 –32.6 (c = 1.0,
CH2Cl2). 1H NMR (400 MHz, CDCl3): δ = 1.45 (d, J = 6.8
Hz, 3 H), 1.53 (s, 9 H), 2.98–3.15 (m, 2 H), 3.30 (dt, J = 14.0,
9.6 Hz, 1 H), 3.60 (dd, J = 14.0, 9.6 Hz, 1 H), 3.97 (d, J = 9.2
Hz, 1 H), 4.89 (t, J = 9.6 Hz, 1 H), 5.29 (d, J = 9.6 Hz, 1 H),
5.98 (q, J = 6.8 Hz, 1 H), 6.51–6.60 (m, 3 H), 6.74–6.77 (m,
2 H), 6.96–7.00 (m, 1 H), 7.18–7.30 (m, 7 H), 7.98 (d, J =
8.4 Hz, 1 H). 13C NMR (100 MHz, CDCl3): δ = 15.9, 23.0,
28.0, 39.5, 51.6, 51.9, 73.1, 84.2, 114.4, 115.5, 117.3, 122.5,
123.8, 126.8, 126.9, 127.0, 127.6, 128.0, 128.7, 129.1,
136.0, 136.5, 138.0, 139.6, 149.9, 174.8. HRMS (FAB): m/z
[M + H]+ calcd for C32H35N2O4: 526.2597; found: 511.2613.
(5R,6S)-tert-Butyl-5-hydroxy-4-oxo-6-phenyl-3-[(S)-1-
phenylethyl]-3,4,5,6-tetrahydro-1H-azocino[5,4-
b]indole-7(2H)-carboxylate (14b): Obtained as a pale
yellow oil (0.84 g, 42%); [α]D20 +17.6 (c = 1.0, CH2Cl2). 1H
NMR (400 MHz, CDCl3): δ = 0.68 (d, J = 6.8 Hz, 3 H), 1.51
(s, 9 H), 2.92–3.43 (m, 4 H), 3.92 (d, J = 9.6 Hz, 1 H), 4.85
(t, J = 9.6 Hz, 1 H), 5.28 (d, J = 9.2 Hz, 1 H), 5.84 (q, J = 6.8
Hz, 1 H), 6.99–7.58 (m, 13 H), 7.94–8.19 (m, 1 H). 13C NMR
(100 MHz, CDCl3): δ = 15.3, 23.1, 28.0, 40.6, 51.4, 51.4,
73.1, 84.4, 114.6, 116.0, 117.2, 122.6, 124.2, 126.8, 127.2,
127.4, 128.1, 128.4, 128.5, 129.1, 136.0, 137.1, 139.5,
140.0, 149.8, 174.6. HRMS (FAB): m/z [M + H]+ calcd for
C32H35N2O4: 526.2597; found: 511.2610.
(15) Birch Debenzylation: A solution of 15b (0.26 g, 0.63
mmol) in anhyd THF (2 mL) was added dropwise to a deep
blue solution of Li (0.030 g, 4.38 mmol) in condensed NH3
(ca. 5 mL) at –78 °C. The reaction mixture was allowed to
stir for 3 h at –78 °C before H2O (3 mL) was added. The
mixture was extracted with EtOAc, dried with Na2SO4 and
evaporated under reduced pressure. The residue was purified
by column chromatography on silica gel, and recrystallized
in CH2Cl2–hexane to afford the corresponding product.
(–)-Norbalasubramide: obtained as a white solid (0.15 g,
79%); mp 251–255 °C (decomp.); [α]D20 –2.9 (c = 0.2,
CHCl3); [α]D20 –3.8 (c = 0.5, MeOH), {[α]D20 –2.5 (c = 0.2,
CHCl3); see ref. 16}. 1H NMR (400 MHz, CDCl3): δ = 3.19–
3.40 (m, 4 H), 3.60–3.71 (m, 1 H), 4.20 (d, J = 9.2 Hz, 1 H),
4.88 (d, J = 9.2 Hz, 1 H), 7.10 (ddd, J = 8.8, 7.2, 1.6 Hz, 2
H), 7.20–7.41 (m, 6 H), 7.44–7.63 (m, 1 H). 13C NMR (100
MHz, CDCl3): δ = 23.8, 40.1, 52.6, 71.9, 106.2, 110.8,
117.2, 119.0, 121.6, 127.2, 128.1, 128.3, 128.5, 134.2,
135.5, 140.0, 176.9. (+)-Norbalasubramide: obtained as a
20
white solid (0.14 g, 76%); mp 251–255 °C (decomp.); [α]D
+3.7 (c = 0.5, MeOH).
(13) Jacquemard, U.; Béneteau, V.; Lefoix, M.; Routier, S.;
Mérour, J.-Y.; Coudert, G. Tetrahedron 2004, 60, 10039.
(14) N-Boc Deprotection: To a solution of lactam 14a (0.40 g,
0.78 mmol) in anhyd THF (2 mL) at r.t. was added TBAF
(16) Zheng, C.; Li, Y.; Yang, Y.; Wang, H.; Cui, H.; Zhang, J.;
Zhao, G. Adv. Synth. Catal. 2009, 351, 1685.
Synlett 2013, 24, 878–882
© Georg Thieme Verlag Stuttgart · New York